{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:47:39Z","timestamp":1762505259119},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s11938-006-0006-7","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T17:14:49Z","timestamp":1180890889000},"page":"497-507","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of hepatitis C cryoglobulinemia: Mission and challenges"],"prefix":"10.1007","volume":"9","author":[{"given":"Zeid","family":"Kayali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas R.","family":"LaBrecque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren N.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"6_CR1","first-page":"80","volume":"32","author":"PA Miescher","year":"1995","unstructured":"Miescher PA, Huang YP, Izui S: Type-II cryoglobulinemia. Semin Hematol 1995, 32:80\u201385.","journal-title":"Semin Hematol"},{"key":"6_CR2","first-page":"156","volume":"52","author":"MM Weintrobe","year":"1933","unstructured":"Weintrobe MM, Buell MV: Hyperproteinemia associated with multiple myeloma. Bull Johns Hopkins Hosp 1933, 52:156.","journal-title":"Bull Johns Hopkins Hosp"},{"key":"6_CR3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00000441-194710000-00009","volume":"214","author":"AB Lerner","year":"1947","unstructured":"Lerner AB, Watson CJ. Studies of cryoglobulins. Unusual purpura associated with the presence of high concentrations of cold precipitable serum globulin. Am J Med Sci 1947, 214:410\u2013415.","journal-title":"Am J Med Sci"},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","volume":"40","author":"M Meltzer","year":"1966","unstructured":"Meltzer M, Franklin EC, Elias K, et al.: Cryoglobulinemia- a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966, 40:837\u2013856.","journal-title":"Am J Med"},{"key":"6_CR5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0140-6736(91)93443-D","volume":"337","author":"JM Durand","year":"1991","unstructured":"Durand JM, Lefevre P, Harle JR, et al.: Cutaneous vasculitis and cryoglobulinaemia type II associated with hepatitis C virus infection. Lancet 1991, 337:499\u2013500.","journal-title":"Lancet"},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","volume":"244","author":"QL Choo","year":"1989","unstructured":"Choo QL, Kuo G, Weiner AJ, et al.: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244:359\u2013362.","journal-title":"Science"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0002-9343(94)90132-5","volume":"96","author":"P Cacoub","year":"1994","unstructured":"Cacoub P, Fabiani FL, Musset L, et al.: Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994, 96:124\u2013132.","journal-title":"Am J Med"},{"key":"6_CR8","first-page":"115","volume":"88","author":"G Monti","year":"1995","unstructured":"Monti G, Galli M, Invernizzi F, et al.: Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM 1995, 88:115\u2013126.","journal-title":"QJM"},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/jhep.2002.35620","volume":"36","author":"Z Kayali","year":"2002","unstructured":"Kayali Z, Buckwold VE, Zimmerman B, et al.: Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis. Hepatology 2002, 36:978\u2013985. A comprehensive meta-analysis of published studies establishing the relationship between HCV, MC, and cirrhosis.","journal-title":"Hepatology"},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","volume":"106","author":"F Lunel","year":"1994","unstructured":"Lunel F, Musset L, Cacoub P, et al.: Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994, 106:1291\u20131300.","journal-title":"Gastroenterology"},{"key":"6_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/B:MEBR.0000043982.17294.9b","volume":"19","author":"D Sene","year":"2004","unstructured":"Sene D, Limal N, Cacoub P: Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis 2004, 19:357\u2013381. An in-depth discussion of HCV extrahepatic complications and the contribution of CGs. This is one of the best reviews of extrahepatic diseases due to HCV currently available.","journal-title":"Metab Brain Dis"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet JC, Clauvel JP, Danon F, et al.: Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974, 57:775\u2013788.","journal-title":"Am J Med"},{"key":"6_CR13","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","volume":"327","author":"V Agnello","year":"1992","unstructured":"Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992, 327:1490\u20131495.","journal-title":"N Engl J Med"},{"key":"6_CR14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.510310326","volume":"31","author":"WN Schmidt","year":"2000","unstructured":"Schmidt WN, Stapleton JT, LaBrecque DR, et al.: Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology. Hepatology 2000, 31:737\u2013744.","journal-title":"Hepatology"},{"key":"6_CR15","first-page":"4","volume":"92","author":"RA Willson","year":"1997","unstructured":"Willson RA: Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1997, 92:4\u201317.","journal-title":"Am J Gastroenterol"},{"key":"6_CR16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.10107","volume":"46","author":"D Vassilopoulos","year":"2002","unstructured":"Vassilopoulos D, Calabrese LH: Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. Arthritis Rheum 2002, 46:585\u2013597. An excellent review of HCV extrahepatic complications of cryoglobulinemia, vasculitis, and treatment strategies.","journal-title":"Arthritis Rheum"},{"key":"6_CR17","first-page":"1275","volume":"16","author":"P Schott","year":"2001","unstructured":"Schott P, Hartmann H, Ramadori G: Hepatitis C virusassociated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment. Histol Histopathol 2001, 16:1275\u20131285.","journal-title":"Histol Histopathol"},{"key":"6_CR18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1523-1755.1998.00028.x","volume":"54","author":"G D\u2019Amico","year":"1998","unstructured":"D\u2019Amico G: Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998, 54:650\u2013671.","journal-title":"Kidney Int"},{"key":"6_CR19","first-page":"1","volume":"50","author":"A Tarantino","year":"1981","unstructured":"Tarantino A, Devecchi A, Montagnino G, et al.: Renal disease in essential mixed cryoglobulinemia. Longterm follow-up of 44 patients. Q J Med 1981, 50:1\u201330.","journal-title":"Q J Med"},{"key":"6_CR20","doi-asserted-by":"crossref","unstructured":"Kayali Z, Tan S, Shinkunas L, et al.: Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans. J Viral Hepat 2006, In press.","DOI":"10.1111\/j.1365-2893.2006.00764.x"},{"key":"6_CR21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/hep.21190","volume":"43","author":"D Saadoun","year":"2006","unstructured":"Saadoun D, Asselah T, Resche-Rigon M, et al.: Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 2006, 43:1337\u20131345.","journal-title":"Hepatology"},{"key":"6_CR22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00007890-199901150-00013","volume":"67","author":"EJ Gane","year":"1999","unstructured":"Gane EJ, Maertens G, Ducatteeuw A, et al.: Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation. Transplantation 1999, 67:78\u201384.","journal-title":"Transplantation"},{"key":"6_CR23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/01.TP.0000164826.84041.F0","volume":"80","author":"SC Rayhill","year":"2005","unstructured":"Rayhill SC, Kirby A, Voigt MD, et al.: Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C. Transplantation 2005, 80:448\u2013456.","journal-title":"Transplantation"},{"issue":"Suppl 13","key":"6_CR24","first-page":"S79","volume":"13","author":"M Crovatto","year":"1995","unstructured":"Crovatto M, Ceselli S, Mazzaro C, et al.: HCV genotypes and cryoglobulinemia. Clin Exp Rheumatol 1995, 13(Suppl 13):S79-S82.","journal-title":"Clin Exp Rheumatol"},{"key":"6_CR25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0168-8278(96)80200-5","volume":"25","author":"L Frangeul","year":"1996","unstructured":"Frangeul L, Musset L, Cresta P, et al.: Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol 1996, 25:427\u2013432.","journal-title":"J Hepatol"},{"key":"6_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00006","volume":"124","author":"AL Zignego","year":"1996","unstructured":"Zignego AL, Ferri C, Giannini C, et al.: Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996, 124:31\u201334.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"6_CR27","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1002\/hep.510260713","volume":"26","author":"KL Lindsay","year":"1997","unstructured":"Lindsay KL: Therapy of hepatitis C: overview. Hepatology 1997, 26(Suppl 1):S71-S77.","journal-title":"Hepatology"},{"key":"6_CR28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, et al.: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347:975\u2013982.","journal-title":"N Engl J Med"},{"key":"6_CR29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/jhep.2000.16661","volume":"32","author":"P Glue","year":"2000","unstructured":"Glue P, Rouzier-Panis R, Raffanel C, et al.: A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. Hepatology 2000, 32:647\u2013653.","journal-title":"Hepatology"},{"key":"6_CR30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchinson JG, Gordon SC, et al.: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001, 358:958\u2013965.","journal-title":"Lancet"},{"key":"6_CR31","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","volume":"339","author":"JG McHutchison","year":"1998","unstructured":"McHutchison JG, Gordon SC, Schiff ER, et al.: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998, 339:1485\u20131492.","journal-title":"N Engl J Med"},{"key":"6_CR32","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2003.038257","volume":"53","author":"BJ Veldt","year":"2004","unstructured":"Veldt BJ, Saracco G, Boyer N, et al.: Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. Gut 2004, 53:1504\u20131508.","journal-title":"Gut"},{"key":"6_CR33","first-page":"1","volume-title":"National Institutes of Health Consensus Statement of Management of Hepatitis C: 2002","author":"National Institutes of Health (NIH) Panel","year":"2006","unstructured":"National Institutes of Health (NIH) Panel: National Institutes of Health Consensus Statement of Management of Hepatitis C: 2002. Bethesda, MD: NIH; 2006:1\u201346."},{"key":"6_CR34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","volume":"132","author":"TJ Liang","year":"2000","unstructured":"Liang TJ, Rehermann B, Seeff LB, et al.: Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000, 132:296\u2013305.","journal-title":"Ann Intern Med"},{"issue":"Suppl 10","key":"6_CR35","first-page":"S296","volume":"11","author":"BR Bacon","year":"2005","unstructured":"Bacon BR, McHutchison JG: Treatment issues with chronic hepatitis C: special populations and pharmacy strategies. Am J Manag Care 2005, 11(Suppl 10):S296-S306.","journal-title":"Am J Manag Care"},{"key":"6_CR36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/088282402317340260","volume":"15","author":"Y He","year":"2002","unstructured":"He Y, Katze MG: To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon. Viral Immunol 2002, 15:95\u2013119.","journal-title":"Viral Immunol"},{"key":"6_CR37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/0002-9343(87)90904-1","volume":"83","author":"L Bonomo","year":"1987","unstructured":"Bonomo L, Casato M, Afeltra A, et al.: Treatment of idiopathic mixed cryoglobulinemia with alphainterferon. Am J Med 1987, 83:726\u2013730.","journal-title":"Am J Med"},{"key":"6_CR38","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood.V78.12.3142.3142","volume":"78","author":"M Casato","year":"1991","unstructured":"Casato M, Lagana B, Antonelli G, et al.: Long-term results of therapy with interferon-alpha for type-II essential mixed cryoglobulinemia. Blood 1991, 78:3142\u20133147.","journal-title":"Blood"},{"key":"6_CR39","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","volume":"81","author":"C Ferri","year":"1993","unstructured":"Ferri C, Marzo E, Longombardo G, et al.: Interferonalpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993, 81:1132\u20131136.","journal-title":"Blood"},{"issue":"Suppl 13","key":"6_CR40","first-page":"S181","volume":"13","author":"C Mazzaro","year":"1995","unstructured":"Mazzaro C, Lacchin T, Moretti M, et al.: Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia. Clin Exp Rheumatol 1995, 13(Suppl 13):S181-S185.","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 13","key":"6_CR41","first-page":"S175","volume":"13","author":"S Migliaresi","year":"1995","unstructured":"Migliaresi S, Tirri G: Interferon in the treatment of mixed cryoglobulinemia. Clin Exp Rheumatol 1995, 13(Suppl 13):S175-S180.","journal-title":"Clin Exp Rheumatol"},{"key":"6_CR42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","volume":"330","author":"R Misiani","year":"1994","unstructured":"Misiani R, Bellavita P, Fenili D, et al.: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994, 330:751\u2013756.","journal-title":"N Engl J Med"},{"key":"6_CR43","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00042737-199711000-00008","volume":"9","author":"LE Adinolfi","year":"1997","unstructured":"Adinolfi LE, Utili R, Zampino R, et al.: Effects of longterm course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia. Eur J Gastroenterol Hepatol 1997, 9:1067\u20131072.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6_CR44","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1365-2036.1999.00581.x","volume":"13","author":"JL Calleja","year":"1999","unstructured":"Calleja JL, Albillos A, Moreno-Otero R, et al.: Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia. Aliment Pharmacol Ther 1999, 13:1179\u20131186.","journal-title":"Aliment Pharmacol Ther"},{"key":"6_CR45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/jir.1996.16.585","volume":"16","author":"M Casaril","year":"1996","unstructured":"Casaril M, Capra F, Gabrielli GB, et al.: Cryoglobulinemia in hepatitis C virus chronic active hepatitis: effects of interferon-alpha therapy. J Interferon Cytokine Res 1996, 16:585\u2013588.","journal-title":"J Interferon Cytokine Res"},{"key":"6_CR46","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V90.10.3865","volume":"90","author":"M Casato","year":"1997","unstructured":"Casato M, Agnello V, Pucillo LP, et al.: Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 1997, 90:3865\u20133873.","journal-title":"Blood"},{"key":"6_CR47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gut.45.1.122","volume":"45","author":"P Cresta","year":"1999","unstructured":"Cresta P, Musset L, Cacoub P, et al.: Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. Gut 1999, 45:122\u2013128.","journal-title":"Gut"},{"key":"6_CR48","first-page":"643","volume":"33","author":"H Hartmann","year":"1995","unstructured":"Hartmann H, Schott P, Polzien F, et al.: Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates [in German]. Z Gastroenterol 1995, 33:643\u2013650.","journal-title":"Z Gastroenterol"},{"key":"6_CR49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-8278(97)80281-4","volume":"27","author":"F Polzien","year":"1997","unstructured":"Polzien F, Schott P, Mihm S, et al.: Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia. J Hepatol 1997, 27:63\u201371.","journal-title":"J Hepatol"},{"key":"6_CR50","first-page":"1847","volume":"90","author":"K Tanaka","year":"1995","unstructured":"Tanaka K, Aiyama T, Imai J, et al.: Serum cryoglobulin and chronic hepatitis C virus disease among Japanese patients. Am J Gastroenterol 1995, 90:1847\u20131852.","journal-title":"Am J Gastroenterol"},{"key":"6_CR51","first-page":"2466","volume":"28","author":"M Naarendorp","year":"2001","unstructured":"Naarendorp M, Kallemuchikkal U, Nuovo GJ, et al.: Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection. J Rheumatol 2001, 28:2466\u20132473.","journal-title":"J Rheumatol"},{"key":"6_CR52","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","volume":"84","author":"F Dammacco","year":"1994","unstructured":"Dammacco F, Sansonno D, Han JH, et al.: Natural interferon-alpha versus its combination with 6-methylprednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 1994, 84:3336\u20133343.","journal-title":"Blood"},{"key":"6_CR53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02990568","volume":"12","author":"VM Lauta","year":"1995","unstructured":"Lauta VM, DeSangro MA: Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia. Med Oncol 1995, 12:223\u2013230.","journal-title":"Med Oncol"},{"key":"6_CR54","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/art.10699","volume":"46","author":"P Cacoub","year":"2002","unstructured":"Cacoub P, Lidove O, Maisonobe T, et al.: Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002, 46:3317\u20133326.","journal-title":"Arthritis Rheum"},{"key":"6_CR55","first-page":"1775","volume":"30","author":"C Mazzaro","year":"2003","unstructured":"Mazzaro C, Zorat F, Comar C, et al.: Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon. J Rheumatol 2003, 30:1775\u20131781.","journal-title":"J Rheumatol"},{"key":"6_CR56","first-page":"2172","volume":"27","author":"E Zuckerman","year":"2000","unstructured":"Zuckerman E, Keren D, Slobodin G, et al.: Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 2000, 27:2172\u20132178.","journal-title":"J Rheumatol"},{"key":"6_CR57","first-page":"421A","volume":"34","author":"WN Schmidt","year":"2001","unstructured":"Schmidt WN, LaBrecque DR, Voigt MD, et al.: Combination antiviral therapy in patients with chronic hepatitis C and cryoglobulinemia. Hepatology 2001, 34:421A.","journal-title":"Hepatology"},{"key":"6_CR58","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0149-2918(02)80042-X","volume":"24","author":"BA Luxon","year":"2002","unstructured":"Luxon BA, Grace M, Brassard D, Bordens R: Pegylated interferons for the treatment of chronic hepatitis C infection. Clin Ther 2002, 24:1363\u20131383.","journal-title":"Clin Ther"},{"key":"6_CR59","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2004.10.031","volume":"42","author":"C Mazzaro","year":"2005","unstructured":"Mazzaro C, Zorat F, Caizzi M, et al.: Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol 2005, 42:632\u2013638.","journal-title":"J Hepatol"},{"key":"6_CR60","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","volume":"52","author":"P Cacoub","year":"2005","unstructured":"Cacoub P, Saadoun D, Limal N, et al.: PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2005, 52:911\u2013915.","journal-title":"Arthritis Rheum"},{"key":"6_CR61","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood.V78.12.3142.3142","volume":"78","author":"M Casato","year":"1991","unstructured":"Casato M, Lagana B, Antonelli G, et al.: Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood 1991, 78:3142\u20133147.","journal-title":"Blood"},{"key":"6_CR62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/ndt\/14.2.281","volume":"14","author":"M Campise","year":"1999","unstructured":"Campise M, Tarantino A: Glomerulonephritis in mixed cryoglobulinaemia: what treatment? Nephrol Dial Transplant 1999, 14:281\u2013283.","journal-title":"Nephrol Dial Transplant"},{"key":"6_CR63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","volume":"55","author":"C Ferri","year":"2002","unstructured":"Ferri C, Zignego AL, Pileri SA: Cryoglobulins. J Clin Pathol 2002, 55:4\u201313.","journal-title":"J Clin Pathol"},{"key":"6_CR64","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1053\/ajkd.2001.29291","volume":"38","author":"G Garini","year":"2001","unstructured":"Garini G, Allegri L, Carnevali L, et al.: Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis. Am J Kidney Dis 2001, 38:E35.","journal-title":"Am J Kidney Dis"},{"key":"6_CR65","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#","volume":"42","author":"P Lamprecht","year":"1999","unstructured":"Lamprecht P, Gause A, Gross WL: Cryoglobulinemic vasculitis. Arthritis Rheum 1999, 42:2507\u20132516.","journal-title":"Arthritis Rheum"},{"key":"6_CR66","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1007\/s10620-005-3059-x","volume":"50","author":"E D\u2019Amico","year":"2005","unstructured":"D\u2019Amico E, Chincoli C, Cacciatore P, et al.: Effects of combined antiviral therapy on asymptomatic mixed cryoglobulinemia in naive patients with chronic hepatitis C virus infection: a preliminary study. Dig Dis Sci 2005, 50:2344\u20132347.","journal-title":"Dig Dis Sci"},{"key":"6_CR67","first-page":"S235","volume":"50","author":"L Quartuccio","year":"2004","unstructured":"Quartuccio L, Soardo G, Romano G, et al.: Treatment of glomerulonephritis in type II mixed cryoglobulinemia with rituximab. Arthritis Rheum 2004, 50:S235.","journal-title":"Arthritis Rheum"},{"key":"6_CR68","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","volume":"101","author":"F Zaja","year":"2003","unstructured":"Zaja F, De Vita S, Mazzaro C, et al.: Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003, 101:3827\u20133834.","journal-title":"Blood"},{"key":"6_CR69","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1525-1594.1995.tb02337.x","volume":"19","author":"H Murai","year":"1995","unstructured":"Murai H, Inaba S, Kira J, et al.: Hepatitis C virus associated cryoglobulinemic neuropathy successfully treated with plasma exchange. Artif Organs 1995, 19:334\u2013338.","journal-title":"Artif Organs"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0006-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-006-0006-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0006-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:48:14Z","timestamp":1587577694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-006-0006-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s11938-006-0006-7","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}